Skip to content

A Prospective Clinical Study of Ultra-short-course Chemotherapy for Spinal Tuberculosis

A Prospective Clinical Study of Ultra-short-course Chemotherapy for Spinal Tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001823
Enrollment
Unknown
Registered
2011-12-14
Start date
2010-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal tuberculosis

Interventions

Ultra-short-course:surgery+Ultra-short-course
standard chemotherapy group:surgery+standard chemotherapy

Sponsors

General Hospital of Ningxia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Spinal tuberculosis was diagnosed according to symptoms, physical signs, imaging examination results, and etiological and histopathological results. Patients receiving initial or repeated chemotherapy were included; 2. no contraindications to surgery were noted; 3. Patients were evaluated and were found to be appropriate candidates for surgical focus debridement for tuberculosis.

Exclusion criteria

Exclusion criteria: 1. Spinal tubeculosis was diagnlosed unclear ,or were excluded by according to etiological and histopathological results; 2. Lost to follow-up; 3. No compliant with the recommended chemotherapy treatment.

Design outcomes

Primary

MeasureTime frame
Erythrocyte sedimentation rate;C-reactive protein;X-ray;Computer Tomography;magnetic resonance imaging;B-mode ultrasound;correction of deformity;ASIA scores;ability to live and work;Bone graft healing;liver and kidney function;side effects of chemotherapy;Bacterial culture and identification of bacteria;

Countries

China

Contacts

Public ContactZili-Wang
wangzlnx@126.com+86 13709515798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026